ACCESS PHARMACEUTICALS

access-pharmaceuticals-logo

Access Pharmaceuticals (ACCP.ob) is an emerging pharmaceuticals company with a focus on oncology and diabetes. Access has one FDA approved treatment for oral mucositis (MuGard) which has been launched commercially in Europe and will be launched elsewhere in 2009. ProLindac, a novel DACH platinum chemotherapy, recently completed a Phase 2a trial in recurrent ovarian cancer and will enter combination trials shortly; ProLindac is partnered in the Far East and ACCP is actively seeking North Am... erican and European co-development partners. Additionally, ACCP has a novel nucleoside analogue, Thiarabine, which will enter Phase 2 leukemia trials this year, a preclinical stage monoclonal antibody (Angiolix) and additional preclinical oncology programs. Also, ACCP has an oral insulin and oral human growth hormone program which is being developed in a sponsored research agreement with a major pharmaceutical company (and for which ACCP is seeking additional development partnerships).

#SimilarOrganizations #People #Website #More

ACCESS PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1974-01-01

Address:
Dallas, Texas, United States

Country:
United States

Website Url:
http://www.accesspharma.com

Total Employee:
11+

Status:
Active

Contact:
8774846946

Email Addresses:
[email protected]

Total Funding:
38.88 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Content Delivery Network Google Universal Analytics Font Awesome Nginx ReCAPTCHA JsDelivr


Similar Organizations

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

Current Employees Featured

not_available_image

David P. Nowotnik
David P. Nowotnik Senior Vice President Research and Development @ Access Pharmaceuticals
Senior Vice President Research and Development

not_available_image

Jeffrey B. Davis
Jeffrey B. Davis President and Chief Executive Officer @ Access Pharmaceuticals
President and Chief Executive Officer

not_available_image

Kerry P. Gray
Kerry P. Gray President,Director & CEO @ Access Pharmaceuticals
President,Director & CEO

not_available_image

Stephen B. Thompson
Stephen B. Thompson Vice President and CFO @ Access Pharmaceuticals
Vice President and CFO

not_available_image

David Ranney
David Ranney Founder @ Access Pharmaceuticals
Founder

Founder


not_available_image

David Ranney

Official Site Inspections

http://www.accesspharma.com

  • Host name: 86-105-245-69.haip.transip.net
  • IP address: 86.105.245.69
  • Location: Netherlands
  • Latitude: 52.3824
  • Longitude: 4.8995
  • Timezone: Europe/Amsterdam

Loading ...

More informations about "Access Pharmaceuticals" on Search Engine